Autor Deborah M.
- SEC CIK
- 0001884671
In the past year, 3 open-market sale filings worth $1.18M and no purchases.
Current role at each company
- HIMS Hims & Hers Health, Inc.Chief Policy Officeras of Aug 20, 2026
- AMRX Amneal Pharmaceuticals, Inc.Directoras of May 12, 2026
- PRDS Pardes Biosciences, Inc.Directoras of Aug 31, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.18M
- 3 filings
- Net
- −$1.18M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Autor Deborah M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HIMS Hims & Hers Health, Inc.
Chief Policy Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 (view filing)4:31 PM ET | Aug 18 | 2 days | Autor Deborah M.Chief Policy Officer | SSaleClass A Common Stock | −16.8K | $27.85 | −$467.1K | −25.5%49.0K after | 10b5-1 |
| Dec 18, 2025 (view filing) | Dec 17 | 1 day | Autor Deborah M.Chief Policy Officer | SSaleClass A Common Stock | −7.05K | $36.71 | −$259.0K | −53.3%6.17K after | 10b5-1 |
AMRX Amneal Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 (view filing) | May 11 | 1 day | Autor Deborah M.Director | SSaleClass A Common Stock | −34.8K | $12.94 | −$450.6K | −27.1%93.7K after | |
| Nov 25, 2024 (view filing) | Nov 21-22 | 4 days | Autor Deborah M.Director | SSaleClass A Common Stock | −40.0K | $8.35 | −$334.1K | −42.8%53.4K after | 2 lots |
| May 20, 2024 (view filing) | May 16-17 | 4 days | Autor Deborah M.Director | SSaleClass A Common Stock | −38.0K | $6.74 | −$256.2K | −28.9%93.4K after | 2 lots |